News - Boehringer Ingelheim, Production

Filter

Popular Filters

FDA issues CRL on empagliflozin, noting manufacturing deficiencies

FDA issues CRL on empagliflozin, noting manufacturing deficiencies

05-03-2014

There was disappointment today for US drug major Eli Lilly and family-owned German pharma firm Boehringer…

Boehringer IngelheimDiabetesEli LillyempagliflozinNorth AmericaPharmaceuticalProductionRegulationUSA

Boehringer’s US injectables to cease production

Boehringer’s US injectables to cease production

07-10-2013

Ben Venue Laboratories, a subsidiary of Boehringer Ingelheim, has decided to cease production by the…

Ben Venue LabsBoehringer IngelheimNorth AmericaPharmaceuticalProduction

SOBI gets FDA approval to manufacture substance for Kineret with partner Boehringer Ingelheim

11-06-2013

Swedish Orphan Biovitrum (STO: SOBI) said today (June 11) that it has received approval from the US Food…

Boehringer IngelheimInflammatory diseasesKineretNorth AmericaPharmaceuticalProductionRegulationSavient PharmaceuticalsSwedish Orphan Biovitrum

Boehringer Ingelheim to build biopharma facility in China

07-06-2013

German family-owned drug major Boehringer Ingelheim has signed a strategic alliance agreement and contract…

Asia-PacificBiotechnologyBoehringer IngelheimFinancialPharmaceuticalProductionShanghai Zhangjiang Biotech

Boehringer Ingelheim gets FDA warning letter on cGMP failures

22-05-2013

German family-owned drug major Boehringer Ingelheim today (May 22) revealed that the US Food and Drug…

Boehringer IngelheimGenericsPharmaceuticalProductionRegulation

Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member

17-05-2013

German family-owned drug major Boehringer Ingelheim said today (May 17) that it is updating health care…

Boehringer IngelheimCombivent RespimatManagementPharmaceuticalProductionRespiratory and Pulmonary

US federal judge approves consent decree with Boehringer's Ben Venue Labs

03-02-2013

The US Food and Drug Administration announced today that a federal judge has approved a consent decree…

Ben Venue LabsBoehringer IngelheimGenericsLegalPharmaceuticalProductionRegulation

SOBI gains EMA approval for change of Kineret producer; Novartis drops NIC002 project

23-01-2013

Swedish Orphan Biovitrum (STO: SOBI) has received approval from the European Medicines Agency for the…

BiotechnologyBoehringer IngelheimCytos BiotechnologyKineretLicensingNIC002NovartisPharmaceuticalProductionRegulationSwedish Orphan Biovitrum

Boehringer Ingelheim partners on DARPin molecules

12-11-2012

German family-owned drug major Boehringer Ingelheim's biopharmaceutical contract manufacturing business…

Boehringer IngelheimDARPinMolecular PartnersPharmaceuticalProduction

Boehringer Ingelheim highlights robust respiratory R&D pipeline; announces investment

01-11-2012

At its 3rd International Research & Development press conference, family-owned German drug major Boehringer…

afatinibBoehringer IngelheimnintedanibolodaterolOncologyPharmaceuticalProductionResearchRespimatRespiratory and Pulmonary

XOMA and Servier sign manufacturing deal with Boehringer for gevokizumab

06-08-2012

US therapeutic antibody discovery firm XOMA Corp (Nasdaq: XOMA) its partner France's Laboratoires Servier…

Boehringer IngelheimgevokizumabLicensingOphthalmicsPharmaceuticalProductionServierXOMA Corp

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top